{
"info": {
"nct_id": "NCT00860860",
"official_title": "Phase I Clinical Study of the Feasibility of Pretargeted Radioimmunotherapy of an Anti-CEA Bispecific Antibody and Lu-177-labeled Peptide in Patients With Advanced Colorectal Cancer",
"inclusion_criteria": "* Patients with CEA expressing advanced colorectal tumors for which no standard treatment is available\n* WHO performance status: 0 or 1\n* Having normal hematological function: Neutrophils > 1.5 x 109/l; Platelet count > 150 x 109/l, without transfusion during the previous month; Hemoglobin > 5.6 mmol/l\n* Total bilirubin < 2 x upper limit of normal (ULN)\n* ASAT, ALAT < 3 x ULN\n* Serum creatinine < 2 x ULN\n* Cockcroft clearance > 50 ml/min\n* Negative pregnancy test for women of child¬bearing potential (urine or serum)\n* Age over 18 years\n* Ability to provide written informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Known metastases to the brain\n* Chemotherapy, external beam radiation or immunotherapy within 4 weeks prior to study. Limited field external beam radiotherapy to prevent pathological fractures is allowed, when unirradiated, evaluable lesions elsewhere are present.\n* Prior angiogenesis inhibitors within 4 weeks; bevacizumab within 8 weeks\n* Cardiac disease with New York Heart Association classification of III or IV\n* Patients who are pregnant, nursing or of reproductive potential and are not practicing an effective method of contraception\n* Any unrelated illness, e.g. active infection, inflammation, medical condition or laboratory abnormalities, which in the judgement of the investigator will significantly affect patients' clinical status\n* Life expectancy shorter than 6 months.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients with CEA expressing advanced colorectal tumors for which no standard treatment is available",
"criterions": [
{
"exact_snippets": "CEA expressing advanced colorectal tumors",
"criterion": "CEA expression",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "advanced colorectal tumors",
"criterion": "advanced colorectal tumors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "no standard treatment is available",
"criterion": "standard treatment availability",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
}
]
},
{
"line": "* WHO performance status: 0 or 1",
"criterions": [
{
"exact_snippets": "WHO performance status: 0 or 1",
"criterion": "WHO performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "* Having normal hematological function: Neutrophils > 1.5 x 109/l; Platelet count > 150 x 109/l, without transfusion during the previous month; Hemoglobin > 5.6 mmol/l",
"criterions": [
{
"exact_snippets": "Neutrophils > 1.5 x 109/l",
"criterion": "neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 1.5,
"unit": "x 10^9/l"
}
}
]
},
{
"exact_snippets": "Platelet count > 150 x 109/l, without transfusion during the previous month",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 150,
"unit": "x 10^9/l"
}
},
{
"requirement_type": "transfusion",
"expected_value": false
}
]
},
{
"exact_snippets": "Hemoglobin > 5.6 mmol/l",
"criterion": "hemoglobin level",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 5.6,
"unit": "mmol/l"
}
}
]
}
]
},
{
"line": "* Total bilirubin < 2 x upper limit of normal (ULN)",
"criterions": [
{
"exact_snippets": "Total bilirubin < 2 x upper limit of normal (ULN)",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* ASAT, ALAT < 3 x ULN",
"criterions": [
{
"exact_snippets": "ASAT, ALAT < 3 x ULN",
"criterion": "ASAT",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "x ULN"
}
}
]
},
{
"exact_snippets": "ASAT, ALAT < 3 x ULN",
"criterion": "ALAT",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Serum creatinine < 2 x ULN",
"criterions": [
{
"exact_snippets": "Serum creatinine < 2 x ULN",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Cockcroft clearance > 50 ml/min",
"criterions": [
{
"exact_snippets": "Cockcroft clearance > 50 ml/min",
"criterion": "Cockcroft clearance",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 50,
"unit": "ml/min"
}
}
]
}
]
},
{
"line": "* Negative pregnancy test for women of child¬bearing potential (urine or serum)",
"criterions": [
{
"exact_snippets": "Negative pregnancy test for women of child¬bearing potential (urine or serum)",
"criterion": "pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
}
]
},
{
"line": "* Age over 18 years",
"criterions": [
{
"exact_snippets": "Age over 18 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Ability to provide written informed consent",
"criterions": [
{
"exact_snippets": "Ability to provide written informed consent",
"criterion": "written informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Known metastases to the brain",
"criterions": [
{
"exact_snippets": "Known metastases to the brain",
"criterion": "brain metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Chemotherapy, external beam radiation or immunotherapy within 4 weeks prior to study. Limited field external beam radiotherapy to prevent pathological fractures is allowed, when unirradiated, evaluable lesions elsewhere are present.",
"criterions": [
{
"exact_snippets": "Chemotherapy ... within 4 weeks prior to study.",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "external beam radiation ... within 4 weeks prior to study.",
"criterion": "external beam radiation",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "immunotherapy within 4 weeks prior to study.",
"criterion": "immunotherapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "Limited field external beam radiotherapy to prevent pathological fractures is allowed, when unirradiated, evaluable lesions elsewhere are present.",
"criterion": "limited field external beam radiotherapy",
"requirements": [
{
"requirement_type": "purpose",
"expected_value": "prevent pathological fractures"
},
{
"requirement_type": "condition",
"expected_value": "unirradiated, evaluable lesions elsewhere are present"
}
]
}
]
},
{
"line": "* Prior angiogenesis inhibitors within 4 weeks; bevacizumab within 8 weeks",
"criterions": [
{
"exact_snippets": "Prior angiogenesis inhibitors within 4 weeks",
"criterion": "prior angiogenesis inhibitors",
"requirements": [
{
"requirement_type": "time since last dose",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "bevacizumab within 8 weeks",
"criterion": "prior bevacizumab",
"requirements": [
{
"requirement_type": "time since last dose",
"expected_value": {
"operator": "<=",
"value": 8,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Cardiac disease with New York Heart Association classification of III or IV",
"criterions": [
{
"exact_snippets": "Cardiac disease",
"criterion": "cardiac disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "New York Heart Association classification of III or IV",
"criterion": "New York Heart Association classification",
"requirements": [
{
"requirement_type": "classification",
"expected_value": [
"III",
"IV"
]
}
]
}
]
},
{
"line": "* Patients who are pregnant, nursing or of reproductive potential and are not practicing an effective method of contraception",
"criterions": [
{
"exact_snippets": "Patients who are pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "nursing",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "of reproductive potential",
"criterion": "reproductive potential",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "not practicing an effective method of contraception",
"criterion": "contraception",
"requirements": [
{
"requirement_type": "practice",
"expected_value": true
}
]
}
]
},
{
"line": "* Any unrelated illness, e.g. active infection, inflammation, medical condition or laboratory abnormalities, which in the judgement of the investigator will significantly affect patients' clinical status",
"criterions": [
{
"exact_snippets": "active infection",
"criterion": "active infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "inflammation",
"criterion": "inflammation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "medical condition",
"criterion": "medical condition",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "laboratory abnormalities",
"criterion": "laboratory abnormalities",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Life expectancy shorter than 6 months.",
"criterions": [
{
"exact_snippets": "Life expectancy shorter than 6 months.",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 6,
"unit": "months"
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}